Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
7
Number of overlapping holdings
23.3%
% of FBT's 31 holdings also in IDNA
15.6%
% of IDNA's 49 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FBT |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
EXELIXIS INC | 3.6% | 4.7% | 3.6% | |
GILEAD SCIENCES INC | 3.5% | 4.8% | 3.5% | |
REGENERON PHARMACEUTICALS | 3.4% | 4.6% | 3.4% | |
BIONTECH SE SPONSORED ADR | 3.2% | 3.5% | 3.2% | |
INCYTE CORP | 3.2% | 4.4% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to IDNA
EXACT SCIENCES CORP | 4.2% | |
BEIGENE LTD. SPONSORED ADR | 3.9% | |
CATALYST PHARMACEUTICAL PART | 3.8% | |
ALKERMES PLC | 3.8% | |
HALOZYME THERAPEUTICS INC | 3.8% | |
REPLIGEN CORP | 3.8% | |
WATERS CORP | 3.6% | |
ILLUMINA INC | 3.5% | |
UNITED THERAPEUTICS CORP | 3.5% | |
CORCEPT THERAPEUTICS INC | 3.5% |
FBT Underweight Relative to IDNA
ROCHE HOLDING LTD | -4.9% | |
BEIGENE, LTD. | -4.8% | |
SANOFI-AVENTIS | -4.4% | |
TAKEDA PHARMACEUTICAL CO LTD | -4.3% | |
REVOLUTION MEDICINES, INC. | -4.2% | |
GSK PLC | -4.1% | |
GENMAB A/S | -3.9% | |
MERCK & CO. INC. | -3.6% | |
ARCELLX, INC. | -3.0% | |
SPRINGWORKS THERAPEUTICS, INC. | -3.0% |